Holen Sie sich die Stockscreener-App
15.29
0.30%
0.0453
Finanzdaten der Seres Therapeutics Inc-Aktie (MCRB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
8.65%
24.88
|
27.24 | 28.84 | 29.17 | 31.34 |
| Operating Income/Loss |
8.65%
-24.88
|
-27.24 | -28.84 | -29.17 | -31.34 |
| Nonoperating Income/Loss |
91.61%
5.026
|
59.92 | 13.20 | -21.86 | -1.525 |
| Income/Loss From Continuing Operations Before Tax |
160.75%
-19.86
|
32.68 | -15.64 | -51.03 | -32.87 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
160.75%
-19.86
|
32.68 | -15.64 | -51.03 | -32.87 |
| Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | - | 139.81 | - |
|
Net Income/Loss
|
160.75%
-19.86
|
32.68 | -15.64 | 88.78 | -32.87 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.47%
8.7437
|
8.7032 | 5.3033 | 152.65 | 151.51 |
| Diluted Average Shares |
0.33%
8.7437
|
8.7147 | 5.3033 | 152.65 | 151.51 |
| Basic Earnings Per Share |
160.37%
-2.27
|
3.76 | -0.11 | 0.58 | -0.22 |
| Diluted Earnings Per Share |
160.53%
-2.27
|
3.75 | -0.11 | 0.58 | -0.22 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.51%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):